Procurement Summary
Country: Macedonia
Summary: Biological Drugs
Deadline: 26 Dec 2025
Posting Date: 27 Nov 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 130951861
Document Ref. No.: 21446/2025
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33600000 - Pharmaceutical products
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
1 L01FA01 Rituximab (originator) concentrate for solution for infusion 500 mg/50ml, 2 L01FA01 Rituximab (biosimilar) concentrate for solution for infusion 500 mg/50ml, 3 L04AB04 Adalimumab (biosimilar) solution for injection 40 mg/0.8 ml 1 pre-filled injection pen, 4 L04AA29 Tofacitinib (originator) film-coated tablet 5 mg tablet, 5 M05BX04 Denosumab solution for injection 60 mg syringe, 6 L04AB06 Golimumab solution for injection 50 mg/0.5 ml syringe, 7 L04AB02 Infliximab powder for concentrate for solution for infusion 100 mg vial, 8 L04AC07 Tocilizumab (originator) solution for injection 162 mg/0.9 ml syringe, 9 L04AB01 Etanercept (originator) solution for injection 50 mg 1 pre-filled injection pen, 10 L04AB01 Etanercept (biosimilar) solution for injection 50 mg 1 pre-filled injection pen,
CPV Descriptions: Pharmaceutical products
Documents
Tender Notice
Document_1.docx
Document_2.doc
Document_3.docx
Document_4.pdf